Polar Asset Management Partners Inc. - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 11 filers reported holding PHOENIX BIOTECH ACQUISITION in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Polar Asset Management Partners Inc. ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q2 2023$1,288,800
+0.6%
120,0000.0%0.02%
+21.1%
Q1 2023$1,281,600
-79.2%
120,000
-80.0%
0.02%
-75.0%
Q4 2022$6,157,226
+1.7%
599,9990.0%0.08%
+4.1%
Q3 2022$6,054,000
+0.7%
599,9990.0%0.07%
+4.3%
Q2 2022$6,012,000
+0.1%
599,9990.0%0.07%
+9.4%
Q1 2022$6,003,000
+1.0%
599,9990.0%0.06%
+1.6%
Q4 2021$5,946,000599,9990.06%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q3 2023
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,103$1,177,7820.32%
METEORA CAPITAL, LLC 169,897$1,841,6830.31%
Mint Tower Capital Management B.V. 141,089$1,5320.24%
BERKLEY W R CORP 47,199$512,5810.03%
Shaolin Capital Management LLC 50,000$5430.02%
CLEAR STREET LLC 73,364$7970.01%
Walleye Capital LLC 47,936$520,5850.00%
Walleye Trading LLC 26,964$292,8290.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,588$114,9850.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders